Catalyst Wire Dossier Catalyst Wire Dossier

RGI-2001

· Regimmune Corporation
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RGI-2001, covering 2019-10-23 to 2024-04-17. Get the full timeline:

Most recent: Clinical Trial Update: RGI-2001 for the Prevention of Acute Graft-vs-Host Disease in Subjects Following Allogeneic Hematopoietic Stem Cell Transplantation [Phase 2]

See pricing